The three-day course offers intensive training on Transcranial Magnetic Stimulation (TMS). TMS is an FDA-cleared treatment for depression, obsessive-compulsive disorder, migraines, smoking cessation and cortical mapping.
Sponsored by the Duke University School of Medicine, the Duke TMS Course includes didactic sessions and hands-on administration of TMS. The didactic sessions with the TMS faculty of Duke University cover all topics relevant to running a TMS clinical service and a TMS research lab, including:
- Device principles and types
- Neuroscience of TMS
- Motor threshold determination
- Treatment technique
- Stimulus dosing
- Risks, complications and contraindications
- Safety screening
- Post-TMS management and continuation treatment
- Clinical and non-clinical research applications
- Emerging brain stimulation techniques
This activity is designed for clinicians and researchers who wish to enhance their knowledge of TMS and related brain stimulation techniques. The course session is capped at 20 participants. Nurses may participate in this course and can receive attendance credit, but not CME credit.
- State the rationale for the use of TMS in depression, obsessive compulsive disorder and off-label conditions
Explain regulatory issues and policies concerning TMS
Name the two main components of transcranial magnetic stimulation devices
Operate the TMS device and correctly use it to determine the optimal site and motor threshold
Describe the findings from TMS research in imaging and motor cortex excitability studies
Apply the indications for use of TMS in depression
Identify the risks and side effects of TMS and describe how to conduct a safety screening
Design a protocol for seizure management during TMS administration
Outline steps necessary to set up a TMS service/lab
The fellowship, currently offered on a quarterly basis, is held on a Saturday from 8:30am to 5pm, Sunday from 8:30 am to 6pm and Monday from 8:30am to 6pm. Attendees must attend all three days of the course in order to receive full continuing education credit for the course. Upcoming dates in 2023 are as follows:
- January 28-30, 2023
- April 22-24, 2023
- July 29-31, 2023
- October 7-9, 2023
The course cost is $3,200 for all participants. Discounts are not available. There are no holds, and registration is first come, first served.
Before registering, please see the COVID-19 Policy and Cancellation Policy below.
The Duke TMS Course only accepts credit card payments.
All participants must be fully vaccinated (including boosters) to register.
The 2023 courses are planned to be held in-person unless otherwise indicated. For in-person attendance at the Visiting Fellowship in Transcranial Magnetic Stimulation Course at Duke University, you must be fully vaccinated for COVID-19 (including boosters) and provide a scan of your vaccination card via email to the course coordinator at email@example.com. Please send your proof of vaccination now. If the course is virtual, proof of vaccination will not be required.
PLEASE NOTE: If the need to transition to a virtual Zoom format arises due to circumstances out of our control, we will let you know via email. We hope that this does not happen, but please understand that the Duke leadership events policy could change depending on evolving COVID-19 circumstances.
During the visiting fellowship, masks are required to be worn at all times. The health and safety of our participants and staff is our priority. Due to the recent rise of COVID-19 and the increased spread of the Delta and Omicron and other variants of the virus, everyone is required to wear a face mask in all Duke Health facilities until further notice. Only approved masks should be worn over the nose and mouth. Gaiters will not be allowed.
Full credit card payment is due at the time of registration. A written notice of cancellation must be received 30 days prior to the start of this activity. A 10% ($320) cancellation fee will be assessed at that time; after that date, cancellation requests cannot be honored and no refund will be issued. In the event that the program is canceled or postponed, we will not be responsible for any travel costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels. Please contact firstname.lastname@example.org with questions.
Asa Cordle, MD
TMS Clinic Director, Partner, Raleigh Psychiatric Associates
Simon W. Davis, PhD
Assistant Professor, Duke Department of Neurology
Wayne Feng, MD
Professor, Duke Department of Neurology
Leah D. Frymi, MD
Staff Psychiatrist, Durham VA Medical Center
Tommy G. Fu, MD
Psychiatrist, Duke Electroconvulsive Therapy Clinic, Duke Regional Hospital
Student, Duke Department of Psychology & Neuroscience
Bruce M. Luber, PhD
Staff Scientist, National Institute of Mental Health
Previously: Associate Professor of Psychiatry at Duke University, Assistant Professor of Psychiatry at Columbia University
Shawn M. McClintock, PhD, MSCS
Associate Professor, Division of Psychology, Department of Psychiatry, UT Southwestern Medical Center
Adjunct Associate Professor, Duke Psychiatry & Behavioral Sciences
Andrada D. Neacsiu, PhD
Assistant Professor, Duke Department of Psychiatry & Behavioral Sciences
Assistant Professor, Duke Department of Family Medicine & Community Health
Angel V. Peterchev, PhD
Associate Professor, Duke Department of Psychiatry & Behavioral Sciences
Departments of Biomedical Engineering, Electrical & Computer Engineering and Neurosurgery (secondary), Duke University
Justin Uzl, MD
Assistant Professor, Duke Department of Psychiatry and Behavioral Sciences
Sandeep Vaishnavi, MD, PhD
Medical Director, MindPath Care Centers Brain Stimulation
Program and Medical Director, MindPath Care Centers Clinical Research Institute
Adjunct Associate, Duke Department of Medicine
Jonathan R. Young, MD
Staff Psychiatrist, Durham VA Medical Center
Consulting Associate, Duke Department of Psychiatry & Behavioral Sciences
The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Statements by industry representatives during the industry device demos and exhibits may not reflect the views and opinions of the course organizers and faculty.
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:
- Asa Cordle, MD
- Simon Davis, PhD
- Leah Fryml, MD
- Tommy Fu, MD
- Sarah H. Lisanby, MD
- Bruce Luber, PhD
- Marisa Spurrell, BA
- Justin Uzl, MD
- Sandeep Vaishnani, MD, PhD
- Eleanor Wood, BSE
- Jonathan Young, MD
The following speaker/planning committee member have indicated that they have relationship(s) with industry to disclose:
- Wayne Feng, MD, FAHA, advisory board for Ipsen, primary investigator for NIH, primary investigator and advisory board for American Heart Association, consultant for Huamed Inc.
- Shawn M. McClintock, PhD, MSCS, consultant for X-Pearson Assessment.
- Angel Peterchev, PhD, Inventor on patents and patent applications on TMS, Royalties for controllable pulse parameter TMS (cTMS/ElevateTMS) patents from Rogue Research, TMS intellectual property and research support from Magstim, TMS device loan and hardware donations from MagVenture, Research funding, device donations, consulting fees, intellectual property on low field magnetic stimulation (LFMS) technology from Tal Medical / Neurex, Consultant: Neuronetics, BTL Industries, Advise Connect Inspire.
- Jonathan R. Young, MD, ownership interest with: Physicians United, General Electric Co, Reinsurance Group of American Inc, Navidea Biopharmaceuticals Inc.
Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.
Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.